Paul R. Sohmer

Eurofins Viracor, Inc. , Inc. provides medical laboratory services. Its client services include account setup, ordering, reporting methods, preventing specimen rejections, and shipping supplies. The firm works with vaccine, pharmaceutical, biotech and medical device developers to provide infectious disease testing, immune monitoring and bio analytical services. The company was founded in 2000 and is headquartered in Lee's Summit, MO.

ViraCor Laboratories LLC is a clinical molecular diagnostic and research laboratory dedicated to detecting and monitoring infections in the immuno-compromised patient population, which includes transplant patients, autoimmune disease patients, preterm infants, Human Immunodeficiency Virus patients and cancer patients. The company is involved in extending organ donation education, promoting scientific education and career exploration, as well as charitable donations. The company was founded in 2000 and is headquartered in Lee's Summit, MO.

Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY.

Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA.

RadPharm is a leading imaging core lab, managing the complete imaging segment of clinical trials for the global pharmaceutical, biotechnology and medical device industries. With greater than 16 years experience supporting over 350 clinical trials, across 60 countries and 6,000 unique sites, RadPharm's vast expertise spans early stage through phase IV studies and all major therapeutic areas. In addition to having a specialty in oncology trials, they also possess deep experience with cardiovascular, musculoskeletal, CNS, diagnostic contrast imaging agents and medical device studies. RadPharm employs board-certified, sub-specialty trained radiologists, nuclear physicians and medical oncologists, uniquely positioning us to focus on the Medicine Behind the ImageTM. Its experienced medical staff interprets data from all major modalities, including, but not limited to, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray, Single Photon Emission Computed Tomography (SPECT), Ultrasound, Positron Emission Tomography (PET) and PET/CT. They provide centralized, independent, unbiased interpretation of medical images for clinical trials, integrated with a proven planning, tracking and implementation process specifically designed to exceed your expectations and timelines. RadPharm speeds delivery of your product to market by supporting your trial program with medical expertise, regulatory know-how and advanced, validated technologies. RadPharm, Inc. provides oncology and medical imaging review services. It also offers radiation therapy QA services, oncology clinical reviews, and complete medical photography services. The company was founded in 1998 by Robert Ford and is headquartered in Princeton, NJ.

Pathway Diagnostics Corp. develops biomedical and biomarker products. It develops biomarkers of disease into novel esoteric tests. The company specializes in the identification, optimization & validation of biomarker assays for all phases of drug development and clinical diagnostic applications makes them a valuable partner for pharmaceutical & biotechnology companies. Pathway Diagnostics is headquartered in Malibu, CA.

Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992

TriPath Imaging, Inc. engages in the development, manufacture, and market of equipment and products for cervical cytology screening. The company was founded on November 15, 1996 and is headquartered in Burlington, NC.